Business Context and Reporting Period
This Form 8-K is a current report filed by Millendo Therapeutics, Inc. (noted as Tempest Therapeutics in metadata, but Millendo in the filing text) on January 7, 2019. The report addresses Item 8.01 (Other Events) regarding the update of the company's corporate presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to announce the availability of an updated corporate presentation attached as Exhibit 99.1.
Material Changes
There are no material financial changes reported in this filing. The only event disclosed is the release of an updated corporate presentation.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, or risk factors within the text of the 8-K itself. These details are contained within the attached Corporate Presentation (Exhibit 99.1), which is incorporated by reference.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name ("Tempest Therapeutics") and the filing registrant name ("Millendo Therapeutics, Inc.").
- Review the attached Exhibit 99.1 (Corporate Presentation) for actual financial data, strategic updates, and risk factors.
- Confirm the filing date of January 7, 2019, aligns with the intended release of the corporate update.